The site will be unavailable from 11:00 PM GMT on Tuesday, 21 July 2026, until 4:00 AM GMT on Wednesday, 22 July 2026, due to scheduled maintenance.

Biologic

22nd Apr 2025

Benralizumab for the treatment of chronic spontaneous urticaria: a plain language summary of the ARROYO study

22nd Jan 2025

Biologic

Benralizumab for the treatment of chronic spontaneous urticaria: a plain language summary of the ARROYO study

Plain language summary of the SHAMAL study on benralizumab treatment for severe eosinophilic asthma